Literature DB >> 10956317

Diabetic nephropathy: evidence for renoprotection and practice.

C E Mogensen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956317      PMCID： PMC1766531          DOI： 10.1136/heart.84.suppl_1.i26

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.

Authors:  E R Mathiesen; E Hommel; H P Hansen; U M Smidt; H H Parving
Journal:  BMJ       Date:  1999-07-03

2.  Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.

Authors:  S Rudberg; R Osterby; H J Bangstad; G Dahlquist; B Persson
Journal:  Diabetologia       Date:  1999-05       Impact factor: 10.122

3.  Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction.

Authors:  C E Mogensen
Journal:  BMJ       Date:  1998-09-12

Review 4.  Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

Authors:  C E Mogensen
Journal:  Diabetes       Date:  1990-07       Impact factor: 9.461

5.  Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy.

Authors:  M M Pedersen; K W Hansen; A Schmitz; K Sørensen; C K Christensen; C E Mogensen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

6.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Authors:  G Maschio; D Alberti; G Janin; F Locatelli; J F Mann; M Motolese; C Ponticelli; E Ritz; P Zucchelli
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

7.  Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients.

Authors:  M M Pedersen; A Schmitz; E B Pedersen; H Danielsen; J S Christiansen
Journal:  Diabet Med       Date:  1988-09       Impact factor: 4.359

8.  Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.

Authors:  C D Agardh; J Garcia-Puig; B Charbonnel; B Angelkort; A H Barnett
Journal:  J Hum Hypertens       Date:  1996-03       Impact factor: 3.012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.